Hansa Biopharma announces it has confidentially submitted a draft registration statement on Form F-1 to the U.S. SEC relating to a potential U.S. IPO
https://investors.hansabiopharma.com/English/press-releases/press-releases-details/2021/Hansa-Biopharma-announces-it-has-confidentially-submitted-a-draft-registration-statement-on-Form-F-1-to-the-U.S.-SEC-relating-to-a-potential-U.S.-IPO/default.aspx
https://investors.hansabiopharma.com/English/press-releases/press-releases-details/2021/Hansa-Biopharma-announces-it-has-confidentially-submitted-a-draft-registration-statement-on-Form-F-1-to-the-U.S.-SEC-relating-to-a-potential-U.S.-IPO/default.aspx
"The number of ADSs that may be offered, the number of underlying ordinary shares that may be issued and the price for such instruments have not yet been determined."
Rettidig omhu.
Rettidig omhu.
Oncopeptides er oppe med +35% idag. Short er godt brændstof til en hurtig stigning.
